Related Experiment Video
Updated: May 1, 2026
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.1K
Oncolytic viruses targeting tumor stem cells
E Antonio Chiocca1, Donald Blair2, R Allan Mufson3
1Authors' Affiliations: Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA and.
Cancer Research
|April 23, 2014
Summary
Experts explored using oncolytic viruses to target tumor stem cells for cancer therapy. The workshop evaluated evidence and identified knowledge gaps for this promising approach.
Area of Science:
- Oncology
- Virology
- Cancer Stem Cell Biology
Background:
- The workshop focused on the potential of oncolytic viruses to target cancer stem cells.
- This approach aims to enhance the efficacy of oncolytic virus therapy for cancer treatment.
Framework:
- Discussion centered on the current state of research for oncolytic viruses targeting stem cells.
- The goal was to assess evidence supporting this therapeutic strategy.
Implementation:
- Seventeen invited experts presented their research findings.
- The event facilitated discussion on the challenges and progress in the field.
Implications:
- Identified critical knowledge gaps hindering the advancement of this cancer therapy.
- Aimed to guide future research directions for more effective oncolytic virotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
02:40Cancer Stem Cells and Tumor Maintenance
4.3K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
02:40Cancer Stem Cells and Tumor Maintenance
2.0K
2.0K
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:57Targeted Cancer Therapies
1.4K
1.4K
02:49Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K